Child-opioid receptor gene variant influences parent-child relations

Neuropsychopharmacology

Volumn 36, Issue 6, 2011, Pages 1165-1170

  Copeland, William E ^a   Sun, Hui ^b   Costello, E Jane ^a   Angold, Adrian ^a   Heilig, Markus A ^b   Barr, Christina S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

childhood; genetics; OPRM1; parent child relations; separation anxiety

Indexed keywords

MU OPIATE RECEPTOR; OPRM1 PROTEIN, HUMAN;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CHILD PARENT RELATION; CRIMINAL BEHAVIOR; EUROPE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL HEALTH; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SUBSTANCE ABUSE; UNITED STATES; COGNITIVE DEFECT; GENE FREQUENCY; GENETIC SCREENING; GENETICS; METABOLISM; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; PARENT; PSYCHOLOGICAL ASPECT; SOCIAL BEHAVIOR; SOCIOPATHY; STANDARD;

ADOLESCENT; CHILD; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; FEMALE; GENE FREQUENCY; GENETIC TESTING; GENETIC VARIATION; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NORTH CAROLINA; PARENT-CHILD RELATIONS; PARENTS; RECEPTORS, OPIOID, MU; SOCIAL BEHAVIOR; SOCIAL BEHAVIOR DISORDERS;

EID: 79954573482     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.251     Document Type: Article

References (37)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV). American Psychiatric Press: Washington, DC.
2. Angold A, Costello EJ (1995). A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). Psychol Med 25: 755-762.
3. Angold A, Costello E (2000). The Child and Adolescent Psychiatric Assessment (CAPA). J Am Acad Child Adolesc Psychiatry 39: 39-48. (Pubitemid 30029898)
4. Angold A, Erkanli A, Farmer E, Fairbank J, Burns B, Keeler G et al (2002). Psychiatric disorder, impairment, and service use in rural African American and white youth. Arch Gen Psychiatry 59: 893-901.
5. Arias A, Feinn R, Kranzler HR (2006). Association of an Asn40Asp (A118G) polymorphism in the [mu]-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 83: 262-268.
6. Barr C, Schwandt M, Lindell BS, Chen SA, Goldman D, Suomi SJ et al (2007). Association of a functional polymorphism in the mu-opioid receptor gene (OPRM1C77G) with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64: 369-376. (Pubitemid 46376788)
7. Barr C, Schwandt M, Lindell BS, Higley JD, Maestripieri D, Goldman D et al (2008). Variation in the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. Proc Natl Acad Sci USA 105: 5277-5281. (Pubitemid 351738546)
8. Bart G, LaForge K, Borg L, Lilly C, Ho A, Kreek M (2006). Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the mu opioid receptor gene. Neuropsychopharma-cology 31: 2313-2317. (Pubitemid 44413212)
9. Befort K, Filliol D, Decaillot F, Gaveriaux-Ruff C, Hoehe M, Kieffer B (2001). A single nucleotide polymorphic mutations in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 276: 3130-3137.
10. Beyer A, Koch T, Schroeder H, Schultz S, Hollt V (2004). Effect of the A118G polymorphism on binding affinity, potency, and agonist-medicated edocytosis, desensitization, and resensitiza-tion of the human mu-opioid receptor. J Neurochem 89: 553-560. (Pubitemid 38534141)
11. Bodnar RJ (2008). Endogenous opiates and behavior: 2007. Peptides 29: 2292-2375. (Pubitemid 50317975)
12. Bond C, LaForge K, Tian M, Melia D, Zhang S, Borg L et al (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95: 9608-9613. (Pubitemid 28506279)
13. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM et al (2005). The A118G single nucleotide polymorphism of the [mu]-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. JPain 6: 159-167. (Pubitemid 40365019)
14. Gibbs RA, Belmont JW, Hardenbol P, Willis TD, Yu F, Yang H et al (2003). The international HapMap project. Nature 426: 789-796.
15. Herman BH, Panksepp J (1978). Effects of morphine and naloxone on separation distress and approach attachment: evidence for opiate mediation of social affect. Pharmacol Biochem Behav 9: 213-220. (Pubitemid 9003916)
16. Ioannidis J (2006). Grading the credibility of molecular evidence for complex disease. Int J Epidemiol 35: 572-577. (Pubitemid 43985538)
17. Insel TR (1997). A neurobiological basis of social attachment. Am J Psychiatry 154: 726-735. (Pubitemid 27230093)
18. Jaffee SR, Belsky J, Harrington H, Caspi A, Moffitt TE (2006). When parents have a history of conduct disorder: how is the caregiving environment affected? J Abnorm Psychol 115: 309-319. (Pubitemid 44212012)
19. Kalin N, Shelton S, Barksdale C (1988). Opiate modulation of separation-induced distress in non-human primates. Brain Res 440: 285-292. (Pubitemid 18049224)
20. Kalin N, Shelton S, Lynn D (1995). Opiate systems in mother and infant primates coordinate intimate contact during reunion. Psychoneuroendocrinology 20: 735-742. (Pubitemid 26022938)
21. Kieffer BL, Evans CJ (2009). Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 56(Suppl 1): 205-212.
22. Knowles PA, Conner RL, Panksepp J (1989). Opiate effects on social behavior of juvenile dogs as a function of social deprivation. Pharmacol Biochem Behav 33: 533-537. (Pubitemid 19237522)
23. Kreek MJ, LaForge KS (2007). Stress responsivity, addiction, and a functional variant of the human Mu-opioid receptor gene. Mol Interv 7: 74-78.
24. Kroslak T, LaForge K, Gianotti R, Ho A, Nielsen D, Kreek M (2007). The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 103: 77-87. (Pubitemid 47404205)
25. Lieb R, Wittchen HU, Hofler M, Fuetsch M, Stein MB, Merikangas KR (2000). Parental psychopathology, parenting styles, and the risk of social phobia in offspring: a prospective-longitudinal community study. Arch Gen Psychiatry 57: 859-866.
26. Marcenko MO, Kemp SP, Larson NC (2000). Childhood experiences of abuse, later substance use, and parenting outcomes among low-income mothers. Am J Orthopsychiatry 70: 316-326.
27. Moles A, Kieffer B, D'Amato F (2004). Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 304: 1983-1986. (Pubitemid 38822193)
28. Nelson EE, Panksepp J (1998). Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepi-nephrine. Neurosci Biobehav Rev 22: 437-452. (Pubitemid 28193973)
29. Panksepp J, Herman B, Conner R, Bishop P, Scott J (1978). The biology of social attachments: opiates alleviate separation distress. Biol Psychiatry 13: 607-618. (Pubitemid 9041469)
30. Ray LA, Hutchison KE (2007). Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64: 1069-1077. (Pubitemid 47360852)
31. Ray WA (2005). Observational studies of drugs and mortality. N Engl J Med 353: 2319-2321. (Pubitemid 41713742)
32. SAS Institute Inc. (2004). SAS/STATs Software: Version 9. SAS Institute: Cary, NC.
33. Simmons D, Self D (2009). Role of mu- and delta-opioid receptors in the nucleus accumbens in cocain-seeking behavior. Neuropsychopharmacology 34: 1946-1957.
34. Spanagel R, Herz A, Shippenberg T (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89: 2046-2050.
35. Sullivan PF, Eaves LJ, Kendler KS, Neale MC (2001). Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry 58: 1015-1024. (Pubitemid 33054098)
36. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S et al (2002). The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26: 106-114. (Pubitemid 34075281)
37. Way BM, Taylor SE, Eisenberger NI (2009). Variation in the mu-opioid receptor gene (OPRM1) is associated with disposi-tional and neural sensitivity to social rejection. Proc Natl Acad Sci USA 106: 15079-15084.